Edwards Lifesciences Corporation EW

86.29 0.56 0.65% as of 25 Sep
Market cap
$49.4B
P/E
49.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Edwards Lifesciences Corporation (EW) P/B ratio

As of 25 September 2026, Edwards Lifesciences Corporation (EW) trades at a P/B ratio of 4.6×. Over the past ten years it has ranged from 3.9× (April 2025) to 14.9× (September 2021); the current reading is higher than 11% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 4.8× 9.68%
FY2024 4.4× (35.56%)
FY2023 6.8× (13.82%)
FY2022 7.9× (42.78%)
FY2021 13.8× 11.43%
FY2020 12.4× 6.02%
FY2019 11.7× 14.78%
FY2018 10.2× 28.20%
FY2017 8.0× 2.46%
FY2016 7.8× 14.23%

Quarterly

Period P/B ratio Change
Jun 2026 4.9× 8.25%
Mar 2026 4.5× (6.87%)
Dec 2025 4.8× 8.23%
Sep 2025 4.5× 2.95%
42 more quarters

Against its own ten years

Low 3.9× High 14.9×
Ten-year median 8.5×
Current reading's percentile 11

P/B ratio against peers

Company P/B ratio
ZBH Zimmer Biomet Holdings, Inc. compare 1.4×
PHG Koninklijke Philips N.V. compare 1.8×
MDT Medtronic PLC compare 2.2×
BSX Boston Scientific Corporation compare 2.6×
GEHC GE HealthCare Technologies Inc. compare 2.7×
STE STERIS plc compare 2.8×
SYK Stryker Corporation compare 4.4×
EW Edwards Lifesciences Corporation 4.6×
DXCM DexCom, Inc. compare 12.6×
Medical Devices industry median 2.5×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on EW